Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Mar 19, 2009


GE Healthcare this week announced Pascale Witz has been appointed president and CEO of GE Healthcare, Medical Diagnostics.

Witz has been in charge of the company's Healthcare Systems Interventional global business, which researches and develops medical diagnostic technologies.

Doug White joined BG Medicine earlier this month as executive vice president and general manager for the company's diagnostics operations.

In the newly created role, White is responsible for the strategic direction and overall management of the company's commercial operations "as it advances a broad portfolio of high-value diagnostic tests toward commercial launch," BG Medicine said in a statement.

White has 24 years of experience in the in vitro diagnostic marketplace. Before joining BG Medicine, he was senior VP of sales and marketing for the Americas and chair of the Americas Management Council at Qiagen. He was also senior VP of commercial operations at Digene before that company was acquired by Qiagen.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.